
样式: 排序: IF: - GO 导出 标记为已读
-
Best Practice Alerts in Electronic Medical Records to Improve Pneumococcal Vaccination in CKD Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-08-17 Sanjana Kapoor, Heena S. Sheth, Ranil DeSilva, Rohit Aggarwal
Abstract not available
-
Long-term Health Care Utilization and Associated Costs After Dialysis-Treated Acute Kidney Injury in Children Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-08-17 Cal H. Robinson, Jennifer Ann Klowak, Nivethika Jeyakumar, Bin Luo, Ron Wald, Amit X. Garg, Danielle M. Nash, Eric McArthur, Jason H. Greenberg, David Askenazi, Cherry Mammen, Lehana Thabane, Stuart Goldstein, Samuel A. Silver, Rulan S. Parekh, Michael Zappitelli, Rahul Chanchlani
Rationale and objective Acute kidney injury (AKI) is common among hospitalized children and is associated with increased hospital length of stay and costs. However, there are limited data on post-discharge healthcare utilization after AKI hospitalization. Our objectives were to evaluate healthcare utilization and physician follow-up patterns after pediatric dialysis-treated AKI. Study design Retrospective
-
Correction of Hypokalemia in Peritoneal Dialysis Patients May Decrease Peritonitis Risk Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-08-13 Beth M. Piraino
Abstract not available
-
Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-08-13 Lesley A. Inker, Morgan E. Grams, Hrefna Guðmundsdóttir, Phil McEwan, Robert Friedman, Aliza Thompson, Daniel E. Weiner, Kerry Willis, Hiddo J.L. Heerspink
In the past decade, advances in the validation of surrogate end points for chronic kidney disease (CKD) progression have heightened interest in evaluating therapies in early CKD. In December 2020, the National Kidney Foundation sponsored a scientific workshop in collaboration with the US Food and Drug Administration (FDA) to explore patient, provider, and payor perceptions of the value of treating
-
Adult-Onset Focal Segmental Glomerulosclerosis With Steroid-Dependent Nephrotic Syndrome Caused by a Novel TBC1D8B Variant: A Case Report and Literature Review Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-08-12 Zhengying Fang, Chunli Zhang, Yuanmeng Jin, Jun Tong, Jian Liu, Xu Hao, Qinjie Weng, Shuwen Yu, Wen Du, Yikai Cai, Qimin Zheng, Li Yang, Hong Ren, Xiaoxia Pan, Jingyuan Xie
Focal and segmental glomerulosclerosis (FSGS) is a histological lesion due to many causes including rare mutations of podocyte related genes. Recently, it has been found that TBC1D8B mutations can lead to early-onset FSGS and steroid-resistant nephrotic syndrome (NS) by influencing endocytic and recycling of nephrin. Here, we report a 19-year-old Chinese patient with NS and normal renal function. He
-
Calciphylaxis and Kidney Disease: A Review Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-08-12 Benjamin Gallo Marin, Ghazal Aghagoli, Susie L. Hu, Cathy M. Massoud, Leslie Robinson-Bostom
Calciphylaxis is a life-threatening complication most often associated with chronic kidney disease that occurs due to the deposition of calcium in dermal and adipose microvasculature. However, this condition may also be seen in patients with acute kidney injury. The high morbidity and mortality associated with calciphylaxis highlight the importance to correctly diagnose and treat this condition. However
-
Psychosocial Distress in Patients With Advanced CKD by Racial Group and Immigrant Status: A Canadian Cross-sectional Study Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-08-07 Navneet Singh, Punithan Thiagalingam, Junayd Hussain, Vishva Shah, Nathaniel Edwards, Eric Lui, Gihad Nesrallah, Charmaine E. Lok, Abdul Aziz Walele, Marta Novak, Carl E. James, Istvan Mucsi
Rationale & Objective Patients with advanced chronic kidney disease (CKD) have been reported to experience profound psychosocial distress. Other work has established that patients with CKD from marginalized populations (including individuals who on the basis of race often face racism and related discrimination, termed “racialization”) experience health care inequities. Given limited information on
-
Effect of Long-term Exercise Training on Physical Performance and Cardiorespiratory Function in Adults With CKD: A Randomized Controlled Trial Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-08-06 Daniel E. Weiner, Christine K. Liu, Shiyuan Miao, Roger Fielding, Leslie I. Katzel, Jamie Giffuni, Andrew Well, Stephen L. Seliger
Rationale and Objective The safety and efficacy of long-term exercise training in reducing physical functional loss in older adults with advanced CKD and co-morbidity is uncertain. Study Design Multi-center, parallel group, randomized controlled trial. Settings and Participants Adults 55 years and older with CKD stage G3b-4 enrolled from centers in Baltimore and Boston. Intervention Twelve months of
-
Proliferative Glomerulonephritis With Hidden Monotypic IgG3κ Deposits: A Case Report Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-08-02 Satoru Kudose, Ibrahim Batal, John Lucia, Purvi Patel, Rajesh K. Soni, Glen S. Markowitz, Vivette D. D’Agati, M. Barry Stokes
Rare cases of IgG-dominant immune complex mediated GN (ICGN) demonstrate immunoglobulin (Ig) subclass restriction without light chain restriction. Some of these cases may represent proliferative glomerulonephritis with monotypic immunoglobulin deposits (PGNMID) in which monotypic Ig is obscured by coexisting polytypic Ig. However, rigorous demonstration of this possibility is lacking to date. Here
-
Vitamin D and Parathyroid Hormone Levels in CKD Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-08-02 Sangeet Dhillon-Jhattu, Rita L. McGill, Jennifer L. Ennis, Elaine M. Worcester, Anna L. Zisman, Fredric L. Coe
Abstract not available
-
Prednisone for Steroid-Sensitive Nephrotic Syndrome: Can We Use Lower Doses for the First Presentation in Children? Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-08-01 Elisabeth Hodson, Deirdre Hahn, Jonathan C. Craig
Abstract not available
-
Dying of Cancer With Kidney Disease Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-08-01 Jeremy R. Chapman
Abstract not available
-
Exercise and Kidney Disease Prevention: Walk This Way Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-21 Stephen Seliger, Daniel Weiner
Abstract not available
-
Australian Rural Caregivers’ Experiences in Supporting Patients With Kidney Failure to Access Dialysis and Kidney Transplantation: A Qualitative Study Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-20 Nicole Scholes-Robertson, Talia Gutman, Amanda Dominello, Martin Howell, Jonathan C. Craig, Germaine Wong, Allison Jaure
-
Water In and Water Out—Or Just the Opposite? The Need to Understand Our Patients’ Illnesses in Their Own Words Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-20 Gitte R. Hinrichs, Line Aas Mortensen
Abstract not available
-
Patient and Clinician Perspectives on Shared Decision Making in Vascular Access Selection: A Qualitative Study Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-20 Meghan J. Elliott, Pietro Ravani, Robert R. Quinn, Matthew J. Oliver, Shannan Love MSLP, Jennifer MacRae, Swapnil Hiremath, Sarah Friesen, Matthew T. James, Kathryn M. King-Shier
Rationale & Objective Collaborative approaches to vascular access (VA) selection are being increasingly encouraged to elicit patients’ preferences and priorities where no unequivocally superior choice exists. We aimed to explore how patients, their caregivers, and clinicians integrate principles of shared decision-making when engaging in VA discussions. Study Design Qualitative description. Setting
-
The Whole Picture Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-19 Ramya Sampath
Abstract not available
-
Prediction of Mortality and Major Adverse Kidney Events in Critically Ill Patients With Acute Kidney Injury Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-19 Javier A. Neyra, Victor Ortiz-Soriano, Lucas J. Liu, Taylor D. Smith, Xilong Li, Donglu Xie, Beverley Adams-Huet, Orson W. Moe, Robert D. Toto, Jin Chen
Rationale & Objective Risk-prediction tools for assisting acute kidney injury (AKI) management have focused on AKI onset but have infrequently addressed kidney recovery. We developed clinical models for risk-stratification of mortality and major adverse kidney events in critically ill patients with incident AKI. Study Design Multicenter cohort study. Setting & Participants 9,587 adult patients admitted
-
-
-
-
Sudden Gross Hematuria in a Hemodialysis Patient Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-20 Jesse Diaz, Jasmeet Gill, Harold M. Szerlip
Abstract not available
-
Performance of New Estimated GFR Equations in Kidney Transplant Recipients: A Step in the Right Direction Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-19 Aimen Liaqat, Joshua J. Augustine, Emilio D. Poggio
Abstract not available
-
Three Pounds and Seven Ounces: My Patient Activation Journey Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-19 Karan K. Mirpuri
Abstract not available
-
A Patient Guides Her Provider: A Dialogue Over Cultural Awareness Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-15 Michael E. Ullian, Odessa M. Wilson
Abstract not available
-
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-14 Mini Michael, Jaap W. Groothoff, Hadas Shasha-Lavsky, John C. Lieske, Yaacov Frishberg, Eva Simkova, Anne-Laure Sellier-Leclerc, Arnaud Devresse, Fitsum Guebre-Egziabher, Sevcan A. Bakkaloglu, Chebl Mourani, Rola Saqan, Richard Singer, Richard Willey, Bahru Habtemariam, John M. Gansner, Ishir Bhan, Tracy McGregor, Daniella Magen
Rationale & Objective Lumasiran reduces urinary and plasma oxalate (POx) in patients with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function. ILLUMINATE-C evaluates the efficacy, safety, pharmacokinetics, and pharmacodynamics of lumasiran in patients with PH1 and advanced kidney disease. Study Design Phase 3, open-label, single-arm trial. Setting & Participants Multinational
-
Diversity in Studies Developing Kidney Function Estimating Equations: Improving Representation, Interpretation, and Utility of Clinical Research Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-14 Flor Alvarado, Abinet Aklilu, Neil R. Powe, Priya Vart, Cynthia Delgado
Abstract not available
-
Living Kidney Donation: It’s Too Hard to Do Good Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-13 Martha Gershun
Abstract not available
-
A Report of 2 Cases of Kidney Involvement in ADA2 Deficiency: Different Disease Phenotypes and the Tissue Response to Type I Interferon Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-09 Giorgio Trivioli, Elena Gelain, Maria L. Angelotti, Fiammetta Ravaglia, Marco Allinovi, Lorenzo Lodi, Leonardo Caroti, Annamaria Buccoliero, Giacomo Emmi, Marco Gattorno, Paola Romagnani, Stefano Volpi, Augusto Vaglio
Adenosine deaminase 2 (ADA2) deficiency is a rare autosomal recessive disease, caused by loss-of-function mutations in the ADA2 gene, and is considered a monogenic form of polyarteritis nodosa (PAN) with frequently positive type I interferon (IFN-I) signature. Renal manifestations in ADA2 deficiency are poorly characterised. We herein report two cases of ADA2 deficiency with different kidney patterns
-
Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-09 Debbie C. Chen, Michael G. Shlipak, Rebecca Scherzer, Nisha Bansal, O Alison Potok, Dena E. Rifkin, Joachim H. Ix, Anthony N. Muiru, Chi-yuan Hsu, Michelle M. Estrella
Rationale & Objective Lower estimated glomerular filtration rate (eGFR) is associated with heart failure (HF) risk. However, eGFR based on cystatin C (eGFRcys) and creatinine (eGFRcr) may differ substantially within an individual. The clinical implications of these differences for risk of HF among persons with chronic kidney disease (CKD) are unknown. Study Design Prospective cohort study. Setting
-
Urate Transporter ABCG2 Function and Asymptomatic Hyperuricemia: A Retrospective Cohort Study of CKD Progression Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-08 Yuki Ohashi, Satoru Kuriyama, Tomoko Nakano, Mai Sekine, Yu Toyoda, Akiyoshi Nakayama, Tappei Takada, Yusuke Kawamura, Takahiro Nakamura, Hirotaka Matsuo, Takashi Yokoo, Kimiyoshi Ichida
Rationale & Objective Treatment of asymptomatic hyperuricemia is not commonly implemented. However, it is unclear whether urate deposition that begins during asymptomatic hyperuricemia can induce nephropathy. Dysfunction of ATP-binding cassette subfamily G member 2 (ABCG2), a urate efflux transporter, leads to elevated serum urate concentration (SUA). We investigated the association between asymptomatic
-
Clinical Factors and Adverse Kidney Outcomes in Children With ANCA-Associated Glomerulonephritis Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-08 Matko Marlais, Tanja Wlodkowski, Nikoleta Printza, Dorothea Kronsteiner, Regina Krisam, Lukas Sauer, Marina Aksenova, Isa Ashoor, Atif Awan, Justine Bacchetta, Ramnath Balasubramanian, Biswanath Basu, Zivile Bekassy, Olivia Boyer, Eugene Yu-hin Chan, Dagmar Csaicsich, Stéphane Decramer, Eiske Dorresteijn, Kjell Tullus
Abstract not available
-
Beyond the Urine Anion Gap: In Support of the Direct Measurement of Urinary Ammonium Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-08 Jaime Uribarri, David S. Goldfarb, Kalani L. Raphael, Joshua L. Rein, John R. Asplin
Ammonium is a major urinary buffer that is necessary for the normal excretion of the daily acid load. Its urinary rate of excretion (UNH4) may be increased several fold in the presence of extrarenal metabolic acidosis. Therefore, measurement of UNH4 can provide important clues about causes of metabolic acidosis. Because UNH4 is not commonly measured in clinical laboratories, the urinary anion gap (UAG)
-
Self-reported Physical Activity and Cardiovascular Events in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-07-07 Jacob W. Bruinius, Mary Hannan, Jinsong Chen, Julia Brown, Mayank Kansal, Natalie Meza, Milda R. Saunders, Jiang He, Ana C. Ricardo, James P. Lash
-
Glomerular Hematuria and the Utility of Urine Microscopy: A Review Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-06-29 Manish K. Saha, David Massicotte-Azarniouch, Monica L. Reynolds, Amy K. Mottl, Ronald J. Falk, J. Charles Jennette, Vimal K. Derebail
Evaluation of hematuria and microscopic examination of urine sediment are commonly used tools by nephrologists in their assessment of glomerular diseases. Certain morphological aspects of urine red blood cells (RBCs) seen by microscopy may help in identifying the source of hematuria as glomerular or not. Recognized signs of glomerular injury are RBC casts or dysmorphic RBCs, in particular acanthocytes
-
Vaccine Attitudes and COVID-19 Vaccine Intention Among Parents of Children With Kidney Disease or Primary Hypertension Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-06-21 Chia-shi Wang, Rinchen Doma, Adrianna L. Westbrook, Jillian Johnson, Evan J. Anderson, Larry A. Greenbaum, Shaheen A. Rana, Roshan P. George, Rouba Garro, Anjali Khanna-Farber, Cam Escoffery, Robert A. Bednarczyk
Rationale & Objective Children with kidney disease and primary hypertension may be more vulnerable to COVID-19 disease. We examined COVID-19 vaccine hesitancy among parents of children with CKD or hypertension. Study Design Sequential explanatory mixed-methods design; survey followed by in-depth interviews. Setting & Participants Parents of children <18 years with kidney disease or primary hypertension
-
-
-
-
Kidney Transplantation in the Setting of Prolonged Dialysis Vintage: It’s About Time Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-06-17 Adrian M. Whelan, Alex Dinh, Elaine Ku
Abstract not available
-
Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-06-13 Silvio Borrelli, Carlo Garofalo, Francis B. Gabbai, Paolo Chiodini, Simona Signoriello, Ernesto Paoletti, Maura Ravera, Elisabetta Bussalino, Vincenzo Bellizzi, Maria Elena Liberti, Luca De Nicola, Roberto Minutolo
Rationale & objectives Ambulatory blood pressure (ABP) monitoring allows concurrent evaluation of BP control and nocturnal BP dipping status, both related to adverse outcomes. However, very few studies have assessed the prognostic role of combining information on dipping status and achieved ABP in patients with chronic kidney disease (CKD). Study Design Prospective observational cohort study. Setting
-
Association of Predicted HLA T-Cell Epitope Targets and T Cell–Mediated Rejection After Kidney Transplantation Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-06-09 Aleksandar Senev, Elisabet Van Loon, Evelyne Lerut, Maarten Coemans, Jasper Callemeyn, Liesbeth Daniëls, Johan Kerkhofs, Priyanka Koshy, Dirk Kuypers, Baptiste Lamarthée, Ben Sprangers, Claire Tinel, Amaryllis H. Van Craenenbroeck, Vicky Van Sandt, Marie-Paule Emonds, Maarten Naesens
-
Association Between Long-term Ambient PM2.5 Exposure and Cardiovascular Outcomes Among US Hemodialysis Patients Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-06-08 Yuzhi Xi, David B. Richardson, Abhijit V. Kshirsagar, Timothy J. Wade, Jennifer E. Flythe, Eric A. Whitsel, Ana G. Rappold
-
Mobile COVID-19 Screening Units: Heat Stress and Kidney Function Among Health Care Workers Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-06-07 Teng-Hsiang Chang, Ching-rYu Lin, Jason Kai Wei Lee, Jerry Che-Jui Chang, Wan-Chin Chen, Hsiao-Yu Yang
Abstract not available
-
Association Between Ultraprocessed Food Consumption and Risk of Incident CKD: A Prospective Cohort Study Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-06-06 Shutong Du, Hyunju Kim, Deidra C. Crews, Karen White, Casey M. Rebholz
-
A Clinical Response–Adjusted Steroid Treatment Protocol for Children With Newly Diagnosed Idiopathic Nephrotic Syndrome Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-06-02 Elena Zion, Yael Borovitz, Hadas Alfandary, Orly Haskin, Shelly Levi, Shoval Shoham, Miriam Davidovits, Amit Dagan
-
The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-06-01 Mark Canney, Heather M. Gunning, Yuyan Zheng, Caren Rose, Arenn Jauhal, Seo Am Hur, Anahat Sahota, Heather N. Reich, Sean J. Barbour
Rationale & Objective Little is known about the risk of cardiovascular disease (CVD) in patients with various primary glomerular diseases. In a population-level cohort of adults with primary glomerular disease, we sought to describe the risk of CVD compared to the general population and the impact of traditional and kidney-related risk factors on CVD risk. Study Design Observational cohort study. Setting
-
Including Race in Pediatric Estimated GFR Equations: Is This a Genuine Need? Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-05-28 Ana Catalina Alvarez-Elías, Guido Filler
Abstract not available
-
Influenza Vaccines in Maintenance Hemodialysis Patients: Does Seroresponse Vary With Different Vaccine Formulations? Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-05-27 Tarek Barbar,Sri Lekha Tummalapalli,Jeffrey Silberzweig
-
Structural Racism in USRDS: A Native Hawaiian Perspective Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-05-26 Kalani L. Raphael
Abstract not available
-
In Reply to Dr Raphael Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-05-26 Kirsten L. Johansen, James B. Wetmore
Abstract not available
-
Initiation Dose of Allopurinol and the Risk of Severe Cutaneous Reactions in Older Adults With CKD: A Population-Based Cohort Study. Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-05-27 Lavanya Bathini,Amit X Garg,Jessica M Sontrop,Matthew A Weir,Peter G Blake,Stephanie N Dixon,Eric McArthur,Flory T Muanda
RATIONALE & OBJECTIVE Allopurinol should be started at lower doses in patients with chronic kidney disease (CKD) to avoid adverse effects. We examined the risk of severe cutaneous reactions in older adults with CKD who were newly prescribed allopurinol at varied doses. STUDY DESIGN Population-based cohort study using linked health care databases. SETTING & PARTICIPANTS Patients in Ontario, Canada (2008-2019)
-
Renal Denervation: A Review Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-05-20 Jimena Rey, Raymond R. Townsend
Uncontrolled hypertension persists as an important health issue, despite the availability of many medications, and non-drug therapies, which lower blood pressure. Increasingly, non-adherence to medication is found in about 2 out of 5 patients with uncontrolled hypertension. In the search for interventions which lower blood pressure without reliance upon adhering to a regimen requiring daily ingestion
-
-
-
-
Hematuria and Proteinuria in a Patient With Recurrent Pulmonary Illnesses: A Quiz Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-05-19 Kelly V. Liang, Brigid K. Ellis, Michael B. Stokes, Richard J. Smith, Xin Gu, Daniel P. Gale
Abstract not available
-
Erratum Regarding “Financial Hardship Among Nonelderly Adults With CKD in the United States” (Am J Kidney Dis. 2021;78[5]:658-668) Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-05-19
Abstract not available
-
Erratum Regarding “Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study” (Am J Kidney Dis. 2022;79[1]:36-44) Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-05-19
Abstract not available
-
Platform Clinical Trials Within Nephrology—Interpreting the Evidence Am. J. Kidney Dis. (IF 11.072) Pub Date : 2022-05-19 Sradha Kotwal, Vlado Perkovic, Hiddo J.L. Heerspink
Abstract not available